ClinVar Miner

Submissions for variant NM_004333.6(BRAF):c.976A>G (p.Ile326Val) (rs775040765)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen RASopathy Variant Curation Expert Panel RCV000462938 SCV000616461 benign Rasopathy 2017-04-18 reviewed by expert panel curation The filtering allele frequency of the c.1772A>G (p.Asn591Ser) variant in the SOS1 gene is 0.054% (11/11524) of Latino chromosomes by the Exome Aggregation Consortium, which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert Panel (BA1; PMID:29493581)
Integrated Genetics/Laboratory Corporation of America RCV000589220 SCV000698350 benign not provided 2017-03-12 criteria provided, single submitter clinical testing Variant summary: The c.976A>G (p.Ile326Val) in BRAF gene is a missense change that involves a non-conserved nucleotide and 5/5 in silico tools predict benign outcome. The variant is located outside of any known functional domain and behaved like wildtype in phosphorylation assay (Razzaque_2007). The variant is present in the large control population datasets of ExAC and gnomAD at a frequency 0.00009 and 0.000075, respectively (11/ 121408 and 21/ 277182 chrs tested, respectively), predominantly in individuals of East Asian descent ( allele frequency: 0.00104 and 0.0007, respectively). These frequencies exceed the maximal estimated expected frequency of a pathogenic allele (0.0000025) in this gene. The variant was identified in one patient with Noonan syndrome who also carried a de novo mutation in BRAF gene, p. E501K, a known pathogenic variant associated with CFC. Taking together, the variant was classified as Benign.
Invitae RCV000462938 SCV000563670 likely benign Rasopathy 2016-05-22 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.